Physician profile
Kailey Markel
NPI 1487355301
$792.41
in general payments reported to CMS, 2019-2025
12 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $427 · 2024: $246 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $792.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $287.82 | 2023-2024 | |
| Abbvie INC. | $119.96 | 2024-2025 | |
| Novo Nordisk INC | $92.95 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Biofrontera INC. | $92.51 | 2023 | Xepi, Bf-Rhodoled, Ameluz |
| Lilly USA, LLC | $42.56 | 2023-2025 | Zepbound, Mounjaro, Taltz |
| Janssen Biotech, INC. | $34.86 | 2023 | Tremfya |
| Pfizer INC. | $29.94 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.95 | 2023 | Spevigo |
| Bayer Healthcare Pharmaceuticals INC. | $19.44 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $18.80 | 2025 | Airsupra |
| Otsuka America Pharmaceutical, INC. | $17.05 | 2025 | Rexulti |
| Exact Sciences Corporation | $14.57 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kailey Markel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.